Aptevo

-$1.01 (-12.56%) Today
+$0.10 (+1.42%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aptevo and other ETFs, options, and stocks.

About APVO

Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527 and APVO603 were developed based on the ADAPTIR modular protein platform technology and APVO442 was developed based on the new ADAPTIR-FLE platform technology.

CEO
Marvin L. White
Employees
58
Headquarters
Seattle, Washington
Founded
2016

APVO Key Statistics

Market cap
34.43M
Price-Earnings ratio
—
Dividend yield
—
Average volume
19.08M
High today
$8.14
Low today
$6.92
Open price
$8.01
Volume
659.54K
52 Week high
$46.66
52 Week low
$6.38

APVO Earnings

-$2.41
-$1.04
$0.32
$1.69
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 31, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure